What Causes Multiple Chemical Sensitivity? The Proposed Mechanisms
Search for the cause of multiple chemical sensitivity and you'll hit the same wall almost everywhere: the cause is "unknown" and the condition is "controversial," often followed, a paragraph later, by the suggestion that it might really be anxiety. If you're the one getting floored by someone's perfume or a freshly painted room, that's a maddening place to be left.
Here's the more honest version. The cause of MCS isn't settled, that part is true, but "unknown" has quietly been used to mean "not real," and that's a different claim entirely. There are several concrete biological mechanisms on the table, some with real evidence behind them, and the science has moved a long way from the 1990s consensus that most of the internet still repeats. Let me walk through the main ones and how strong each actually is.
The short answer
MCS almost certainly isn't one single thing with one single cause. The leading proposed mechanisms are a loss of chemical tolerance after an initiating exposure (the TILT model), oversensitive chemical-sensing receptors, a sensitized brain and nervous system, neurogenic inflammation, mast cell activation, and inherited differences in how people detoxify chemicals, with learned nervous-system responses layered on top. They aren't rivals so much as pieces of the same machine, and the evidence is stronger for some than others.
A 2023 review by Molot and colleagues in Neuroscience & Biobehavioral Reviews titled, pointedly, "Multiple chemical sensitivity: It's time to catch up to the science," argues that MCS is a genuine biological condition centered on receptor sensitization, and that continuing to call it merely controversial ignores what's been measured. That framing is the one worth starting from.
Loss of tolerance after an initiating exposure (TILT)
The overarching framework is TILT, Toxicant-Induced Loss of Tolerance, developed by the researcher Claudia Miller. It describes MCS as a two-stage process. First an initiating exposure, either one large hit or a sustained low-grade one, such as pesticides, solvents, a remodel or a water-damaged building, breaks the body's normal tolerance for chemicals. After that, tiny everyday exposures that never used to register start provoking symptoms, and the list of triggers widens over time.
TILT is best understood as the shape of the illness rather than the molecular cause. Its strength is that it matches what people actually report, again and again: a clear "before and after" tied to an exposure. It's measured with a validated questionnaire, the QEESI, which is why it's more than an anecdote. What TILT doesn't do by itself is name the machinery underneath, and that's what the rest of these mechanisms try to fill in.
Oversensitive chemical-sensing receptors (TRP channels)
This is the mechanism that most directly answers the central puzzle of MCS: how can a dose far too low to harm most people reliably make someone ill? The answer several researchers now favor is that the sensors themselves have been turned up. Your airways and nerves are studded with TRP receptors, especially TRPV1 and TRPA1, which detect irritants and chemical smells. If these become sensitized, ordinary low concentrations trigger a response that would normally take a much larger dose.
This receptor-sensitization model is the centerpiece of the Molot 2023 review, and it fits older observations that chemically sensitive people show heightened responses to capsaicin, the compound that acts on TRPV1. It's currently the most compelling account of the "why such low doses" problem, and it connects the nose and airways to the whole-body reaction.
A sensitized brain and nervous system
Alongside the receptors, the central nervous system itself appears to get sensitized, so the system overreacts to a signal it has learned to treat as dangerous. Iris Bell's neural sensitization model proposed exactly this, and in chemically sensitive people researchers have measured objective differences, including changes in EEG alpha activity and in skin conductance compared with controls.
Brain imaging is suggestive but not clean. Heuser and Wu reported deep subcortical and limbic hypermetabolism on PET scans in MCS patients, which fits the idea of a sensitized limbic system, but two other PET studies found no resting brain pattern specific to MCS. So there's a real signal here worth taking seriously, and it isn't yet consistent enough to call settled. The limbic angle also matters because the limbic system links smell directly to emotion and threat, which is part of why an odor can set off a full-body response.
Neurogenic inflammation
This mechanism explains how a reaction that starts at the nose or airway becomes a body-wide event. Unmyelinated c-fiber nerves in the respiratory lining respond to irritants by releasing substance P and related signals, which drives inflammation, and through the central nervous system a trigger at one site can produce inflammation at distant sites. Neurogenic inflammation is a well-established process in general, and applying it to MCS gives a plausible bridge from a single sniff to a cascade of symptoms.
Mast cell activation
The immune contribution most likely to matter is mast cell activation. Mast cells sit in the skin, gut and airways loaded with histamine and other mediators, and if they over-react they produce exactly the multisystem symptoms MCS is known for. A serious research thread now argues that mast cell activation may be a central engine of chemical intolerance rather than a separate condition. In 544 people with mast cell activation syndrome, 50 to 60% also screened as very suggestive of chemical intolerance, and the two scores rose together. I go through that overlap in detail in MCAS vs MCS, which is worth reading alongside this.
Impaired detoxification and genetic susceptibility
Part of the question isn't only what happens, but who it happens to, and here the suspicion is that some people clear chemicals less efficiently because of inherited differences in their detox enzymes. The evidence is genuinely mixed. In one study of 203 people with MCS and 162 controls, McKeown-Eyssen and colleagues found differences in the CYP2D6 and NAT2 enzymes, and Schnakenberg's group, comparing 248 sensitive with 273 less-sensitive people, found variants in glutathione S-transferase genes and NAT2. But Berg and colleagues, in a larger sample of 96 MCS cases against 1,207 controls, found no significant difference in the variants they tested. So genetics likely sets susceptibility for some people without being the whole story, and it's the line of evidence most in need of larger, cleaner studies.
Oxidative stress and the nitric oxide theory
Martin Pall proposed that MCS runs on a self-sustaining biochemical loop, in which NMDA receptor activation drives up nitric oxide and peroxynitrite, a damaging oxidant, which then keeps the cycle going. Markers of oxidative stress do turn up elevated in some studies. This one is mechanistically detailed and biologically plausible, and it remains more a compelling hypothesis than a proven pathway, but it dovetails with the receptor and sensitization models rather than competing with them.
Is multiple chemical sensitivity psychological?
This is the explanation the mainstream reaches for first, and it deserves an honest answer rather than a defensive one. There is real evidence that expectation and conditioning shape symptoms: in controlled work by Zucco and colleagues, a harmless odor labeled "harmful" produced more symptoms than the same odor labeled "harmless," and people reacted even to blank samples they believed were chemicals. Learning and attention clearly play a part.
But two things get quietly smuggled in when this becomes the whole explanation. First, a conditioned response is a physical one. When the limbic system learns to treat an odor as a threat and fires accordingly, that is a real neural process, not an imagined illness, and it sits right alongside the sensitization models above rather than replacing them. Second, expectation shaping symptoms is true of nearly every condition in medicine, and we don't use it to wave away the others. The conditioning evidence belongs in the picture. It doesn't get to be the whole frame, and it never justified telling people their reactions weren't real.
So what does this mean?
The most useful takeaway is that "cause unknown" was always an overstatement dressed as caution. No single mechanism has been nailed down, which is true of many real conditions, but the leading candidates converge on the same story: a susceptible nervous and immune system, primed by an exposure, that now overreacts to doses everyone else tolerates. That points treatment in a clear direction even without a final answer, which is to cut the total chemical and exposure load so the sensitized system stops being provoked, and to work on calming that system down. If a water-damaged building was the initiating hit, that's where to start, and I cover the practical side in supplements for mold exposure. Because so much of this runs through a sensitized nervous system, the same regulation work that helps a dysregulated nervous system is relevant here too.
The bottom line
Multiple chemical sensitivity doesn't have one proven cause, but it has several well-defined proposed mechanisms, and the strongest of them, receptor and nervous-system sensitization after a triggering exposure, give a coherent account of why tiny doses cause real, body-wide symptoms. The mast cell link ties it to the broader world of immune over-reactivity, genetics explains why some people are more vulnerable, and conditioning adds a real but partial layer. What the evidence does not support is the old shrug that it's probably all in your head.
Related reading: MCAS vs MCS · CIRS and sick building syndrome · Supplements for mold exposure · Body